Literature DB >> 29021137

DDB2 Is a Novel Regulator of Wnt Signaling in Colon Cancer.

Shuo Huang1, Damiano Fantini1, Bradley J Merrill1,2, Srilata Bagchi3, Grace Guzman4, Pradip Raychaudhuri5,6.   

Abstract

Deregulation of the Wnt/β-catenin signaling pathway drives the development of colorectal cancer, but understanding of this pathway remains incomplete. Here, we report that the damage-specific DNA-binding protein DDB2 is critical for β-catenin-mediated activation of RNF43, which restricts Wnt signaling by removing Wnt receptors from the cell surface. Reduced expression of DDB2 and RNF43 was observed in human hyperplastic colonic foci. DDB2 recruited EZH2 and β-catenin at an upstream site in the Rnf43 gene, enabling functional interaction with distant TCF4/β-catenin-binding sites in the intron of Rnf43 This novel activity of DDB2 was required for RNF43 function as a negative feedback regulator of Wnt signaling. Mice genetically deficient in DDB2 exhibited increased susceptibility to colon tumor development in a manner associated with higher abundance of the Wnt receptor-expressing cells and greater activation of the downstream Wnt pathway. Our results identify DDB2 as both a partner and regulator of Wnt signaling, with an important role in suppressing colon cancer development. Cancer Res; 77(23); 6562-75. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29021137      PMCID: PMC5712251          DOI: 10.1158/0008-5472.CAN-17-1570

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

Review 1.  Activation and repression of wingless/Wnt target genes by the TCF/LEF-1 family of transcription factors.

Authors:  H C Korswagen; H C Clevers
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1999

2.  Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.

Authors:  W Liu; X Dong; M Mai; R S Seelan; K Taniguchi; K K Krishnadath; K C Halling; J M Cunningham; L A Boardman; C Qian; E Christensen; S S Schmidt; P C Roche; D I Smith; S N Thibodeau
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

3.  Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF.

Authors:  Jurian Schuijers; Michal Mokry; Pantelis Hatzis; Edwin Cuppen; Hans Clevers
Journal:  EMBO J       Date:  2014-01-10       Impact factor: 11.598

4.  RNF43 is frequently mutated in colorectal and endometrial cancers.

Authors:  Marios Giannakis; Eran Hodis; Xinmeng Jasmine Mu; Mai Yamauchi; Joseph Rosenbluh; Kristian Cibulskis; Gordon Saksena; Michael S Lawrence; Zhi Rong Qian; Reiko Nishihara; Eliezer M Van Allen; William C Hahn; Stacey B Gabriel; Eric S Lander; Gad Getz; Shuji Ogino; Charles S Fuchs; Levi A Garraway
Journal:  Nat Genet       Date:  2014-10-26       Impact factor: 38.330

5.  PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation.

Authors:  Hae-Yun Jung; Sohee Jun; Moonsup Lee; Han-Cheon Kim; Xin Wang; Hong Ji; Pierre D McCrea; Jae-Il Park
Journal:  Mol Cell       Date:  2013-09-19       Impact factor: 17.970

6.  The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated β-catenin by sequestering TCF4 to the nuclear membrane.

Authors:  Anke Loregger; Martina Grandl; Raquel Mejías-Luque; Michael Allgäuer; Kathrin Degenhart; Verena Haselmann; Christina Oikonomou; Pantelis Hatzis; Klaus-Peter Janssen; Ulrich Nitsche; Dietmar Gradl; Olaf van den Broek; Olivier Destree; Kurt Ulm; Michael Neumaier; Behnam Kalali; Andreas Jung; Ignacio Varela; Roland M Schmid; Roland Rad; Dirk H Busch; Markus Gerhard
Journal:  Sci Signal       Date:  2015-09-08       Impact factor: 8.192

7.  Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness.

Authors:  Rama Pai; Andrzej S Tarnawski; Teresa Tran
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

8.  Wnt2 complements Wnt/β-catenin signaling in colorectal cancer.

Authors:  Youn-Sang Jung; Sohee Jun; Sun Hye Lee; Amrish Sharma; Jae-Il Park
Journal:  Oncotarget       Date:  2015-11-10

9.  Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells.

Authors:  Oksana Voloshanenko; Gerrit Erdmann; Taronish D Dubash; Iris Augustin; Marie Metzig; Giusi Moffa; Christian Hundsrucker; Grainne Kerr; Thomas Sandmann; Benedikt Anchang; Kubilay Demir; Christina Boehm; Svenja Leible; Claudia R Ball; Hanno Glimm; Rainer Spang; Michael Boutros
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions.

Authors:  A Rose Brannon; Efsevia Vakiani; Brooke E Sylvester; Sasinya N Scott; Gregory McDermott; Ronak H Shah; Krishan Kania; Agnes Viale; Dayna M Oschwald; Vladimir Vacic; Anne-Katrin Emde; Andrea Cercek; Rona Yaeger; Nancy E Kemeny; Leonard B Saltz; Jinru Shia; Michael I D'Angelica; Martin R Weiser; David B Solit; Michael F Berger
Journal:  Genome Biol       Date:  2014-08-28       Impact factor: 13.583

View more
  14 in total

Review 1.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

2.  Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer.

Authors:  Amit K Srivastava; Ananya Banerjee; Tiantian Cui; Chunhua Han; Shurui Cai; Lu Liu; Dayong Wu; Ri Cui; Zaibo Li; Xiaoli Zhang; Guozhen Xie; Karuppaiyah Selvendiran; Srinivas Patnaik; Adam R Karpf; Jinsong Liu; David E Cohn; Qi-En Wang
Journal:  Cancer Res       Date:  2019-03-20       Impact factor: 12.701

Review 3.  A protein with broad functions: damage-specific DNA-binding protein 2.

Authors:  Ning Bao; Jiguang Han; Huimin Zhou
Journal:  Mol Biol Rep       Date:  2022-10-03       Impact factor: 2.742

Review 4.  Expanding molecular roles of UV-DDB: Shining light on genome stability and cancer.

Authors:  Maria Beecher; Namrata Kumar; Sunbok Jang; Vesna Rapić-Otrin; Bennett Van Houten
Journal:  DNA Repair (Amst)       Date:  2020-04-27

5.  NER-factor DDB2 regulates HIF1α and hypoxia-response genes in HNSCC.

Authors:  Prashant V Bommi; Vaibhav Chand; Nishit K Mukhopadhyay; Pradip Raychaudhuri; Srilata Bagchi
Journal:  Oncogene       Date:  2019-11-18       Impact factor: 9.867

6.  DJ-1 promotes colorectal cancer progression through activating PLAGL2/Wnt/BMP4 axis.

Authors:  Jing Zhou; Hao Liu; Lian Zhang; Xin Liu; Chundong Zhang; Yitao Wang; Qing He; Ying Zhang; Yi Li; Quanmei Chen; Lu Zhang; Kui Wang; Youquan Bu; Yunlong Lei
Journal:  Cell Death Dis       Date:  2018-08-29       Impact factor: 8.469

7.  EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair.

Authors:  Allyson E Koyen; Matthew Z Madden; Dongkyoo Park; Elizabeth V Minten; Priya Kapoor-Vazirani; Erica Werner; Neil T Pfister; Ramona Haji-Seyed-Javadi; Hui Zhang; Jie Xu; Nikita Deng; Duc M Duong; Turner J Pecen; Zoë Frazier; Zachary D Nagel; Jean-Bernard Lazaro; Kent W Mouw; Nicholas T Seyfried; Carlos S Moreno; Taofeek K Owonikoko; Xingming Deng; David S Yu
Journal:  Oncogene       Date:  2020-05-26       Impact factor: 9.867

8.  DDB2 regulates Epithelial-to-Mesenchymal Transition (EMT) in Oral/Head and Neck Squamous Cell Carcinoma.

Authors:  Prashant V Bommi; Sriram Ravindran; Pradip Raychaudhuri; Srilata Bagchi
Journal:  Oncotarget       Date:  2018-10-05

9.  TMEM59 potentiates Wnt signaling by promoting signalosome formation.

Authors:  Jan P Gerlach; Ingrid Jordens; Daniele V F Tauriello; Ineke van 't Land-Kuper; Jeroen M Bugter; Ivar Noordstra; Johanneke van der Kooij; Teck Y Low; Felipe X Pimentel-Muiños; Despina Xanthakis; Nicola Fenderico; Catherine Rabouille; Albert J R Heck; David A Egan; Madelon M Maurice
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-09       Impact factor: 11.205

Review 10.  The role of histone methylation in the development of digestive cancers: a potential direction for cancer management.

Authors:  Yuan Chen; Bo Ren; Jinshou Yang; Huanyu Wang; Gang Yang; Ruiyuan Xu; Lei You; Yupei Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.